- call +1-201-465-4211
- email sales@mrinsights.biz
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most common inflammatory bowel diseases are ulcerative colitis and Crohns disease.
Scope of the Report:
The growth in prevalence of inflammatory bowel diseases such as ulcerative colitis and Crohn's disease majorly drives the growth of the market. In addition, increase in intake of unhealthy food and drinks, and sedentary and stressful lifestyle propels the growth of the market. The increase in healthcare expenditure by government and private organizations is anticipated to increase the market growth.
The worldwide market for Inflammatory Bowel Disease Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Inflammatory Bowel Disease Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Abbott Laboratories
Biocon Ltd
F. Hoffmann-La Roche AG
Johnson and Johnson
Mylan Pharmaceuticals Ltd.
Novartis AG
Pfizer Inc.
Quest Medical, Inc.
Sanofi S.A.
Takeda Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Ulcerative Colitis
Crohns Disease
Indeterminate Colitis
Others
Market Segment by Applications, can be divided into
Amino-salicylates
Antibiotics
Corticosteroids
Immunomodulators
Biologics
Others
There are 15 Chapters to deeply display the global Inflammatory Bowel Disease Drugs market.
Chapter 1, to describe Inflammatory Bowel Disease Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Inflammatory Bowel Disease Drugs, with sales, revenue, and price of Inflammatory Bowel Disease Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Inflammatory Bowel Disease Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Inflammatory Bowel Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Inflammatory Bowel Disease Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Inflammatory Bowel Disease Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Ulcerative Colitis
1.2.2 Crohns Disease
1.2.3 Indeterminate Colitis
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Amino-salicylates
1.3.2 Antibiotics
1.3.3 Corticosteroids
1.3.4 Immunomodulators
1.3.5 Biologics
1.3.6 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Inflammatory Bowel Disease Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Biocon Ltd
2.2.1 Business Overview
2.2.2 Inflammatory Bowel Disease Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Biocon Ltd Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 F. Hoffmann-La Roche AG
2.3.1 Business Overview
2.3.2 Inflammatory Bowel Disease Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 F. Hoffmann-La Roche AG Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Johnson and Johnson
2.4.1 Business Overview
2.4.2 Inflammatory Bowel Disease Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson and Johnson Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mylan Pharmaceuticals Ltd.
2.5.1 Business Overview
2.5.2 Inflammatory Bowel Disease Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mylan Pharmaceuticals Ltd. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis AG
2.6.1 Business Overview
2.6.2 Inflammatory Bowel Disease Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis AG Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer Inc.
2.7.1 Business Overview
2.7.2 Inflammatory Bowel Disease Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Inc. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Quest Medical, Inc.
2.8.1 Business Overview
2.8.2 Inflammatory Bowel Disease Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Quest Medical, Inc. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sanofi S.A.
2.9.1 Business Overview
2.9.2 Inflammatory Bowel Disease Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi S.A. Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Takeda Pharmaceutical
2.10.1 Business Overview
2.10.2 Inflammatory Bowel Disease Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Takeda Pharmaceutical Inflammatory Bowel Disease Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Inflammatory Bowel Disease Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Inflammatory Bowel Disease Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Inflammatory Bowel Disease Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Inflammatory Bowel Disease Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Inflammatory Bowel Disease Drugs Market Analysis by Regions
4.1 Global Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Inflammatory Bowel Disease Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
4.5 South America Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
5 North America Inflammatory Bowel Disease Drugs by Countries
5.1 North America Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Inflammatory Bowel Disease Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Inflammatory Bowel Disease Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
6 Europe Inflammatory Bowel Disease Drugs by Countries
6.1 Europe Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Inflammatory Bowel Disease Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Inflammatory Bowel Disease Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
6.3 UK Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
6.4 France Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Inflammatory Bowel Disease Drugs by Countries
7.1 Asia-Pacific Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Inflammatory Bowel Disease Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Inflammatory Bowel Disease Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
7.5 India Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
8 South America Inflammatory Bowel Disease Drugs by Countries
8.1 South America Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Inflammatory Bowel Disease Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Inflammatory Bowel Disease Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Inflammatory Bowel Disease Drugs by Countries
9.1 Middle East and Africa Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Inflammatory Bowel Disease Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Inflammatory Bowel Disease Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Inflammatory Bowel Disease Drugs Sales and Growth Rate (2013-2018)
10 Global Inflammatory Bowel Disease Drugs Market Segment by Type
10.1 Global Inflammatory Bowel Disease Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Inflammatory Bowel Disease Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Inflammatory Bowel Disease Drugs Revenue and Market Share by Type (2013-2018)
10.2 Ulcerative Colitis Sales Growth and Price
10.2.1 Global Ulcerative Colitis Sales Growth (2013-2018)
10.2.2 Global Ulcerative Colitis Price (2013-2018)
10.3 Crohns Disease Sales Growth and Price
10.3.1 Global Crohns Disease Sales Growth (2013-2018)
10.3.2 Global Crohns Disease Price (2013-2018)
10.4 Indeterminate Colitis Sales Growth and Price
10.4.1 Global Indeterminate Colitis Sales Growth (2013-2018)
10.4.2 Global Indeterminate Colitis Price (2013-2018)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2013-2018)
10.5.2 Global Others Price (2013-2018)
11 Global Inflammatory Bowel Disease Drugs Market Segment by Application
11.1 Global Inflammatory Bowel Disease Drugs Sales Market Share by Application (2013-2018)
11.2 Amino-salicylates Sales Growth (2013-2018)
11.3 Antibiotics Sales Growth (2013-2018)
11.4 Corticosteroids Sales Growth (2013-2018)
11.5 Immunomodulators Sales Growth (2013-2018)
11.6 Biologics Sales Growth (2013-2018)
11.7 Others Sales Growth (2013-2018)
12 Inflammatory Bowel Disease Drugs Market Forecast (2018-2023)
12.1 Global Inflammatory Bowel Disease Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Inflammatory Bowel Disease Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Inflammatory Bowel Disease Drugs Market Forecast (2018-2023)
12.2.2 Europe Inflammatory Bowel Disease Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Inflammatory Bowel Disease Drugs Market Forecast (2018-2023)
12.2.4 South America Inflammatory Bowel Disease Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Inflammatory Bowel Disease Drugs Market Forecast (2018-2023)
12.3 Inflammatory Bowel Disease Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Inflammatory Bowel Disease Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Inflammatory Bowel Disease Drugs Market Share Forecast by Type (2018-2023)
12.4 Inflammatory Bowel Disease Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Inflammatory Bowel Disease Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Inflammatory Bowel Disease Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Inflammatory Bowel Disease Drugs Picture
Table Product Specifications of Inflammatory Bowel Disease Drugs
Figure Global Sales Market Share of Inflammatory Bowel Dise
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
